Cargando…
Managing chronic hepatitis C in the difficult-to-treat patient
Patients with chronic hepatitis C virus (HCV) infection and disease-related complications – among them cirrhosis and liver failure – pose a particular management challenge. Some of these patients may fail to respond to current therapy (non-responders), and some are affected so severely that treatmen...
Autores principales: | Kemmer, Nyingi, Neff, Guy W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779464/ https://www.ncbi.nlm.nih.gov/pubmed/18036096 http://dx.doi.org/10.1111/j.1478-3231.2007.01613.x |
Ejemplares similares
-
Update on the management of cirrhosis – focus on cost-effective preventative strategies
por: Neff, Guy W, et al.
Publicado: (2013) -
Therapeutic Success of Rifaximin for Clostridium difficile Infection Refractory to Metronidazole and Vancomycin
por: Tannous, George, et al.
Publicado: (2010) -
Novel drugs in the management of difficult-to-treat hepatitis C genotypes
por: Cartwright, Emily J, et al.
Publicado: (2013) -
Are There Still Difficult-to-Treat Patients with Chronic Hepatitis C in the Era of Direct-Acting Antivirals?
por: Pabjan, Paweł, et al.
Publicado: (2022) -
Patients with Haemoglobinopathies and Chronic Hepatitis C: A Real Difficult to Treat Population in 2016?
por: Zachou, Kalliopi, et al.
Publicado: (2017)